IDO1 and neoplasm: We are currently exploring a means to determine the imaging potential of the 1MTrp pharmacokinetic platform in tumor-bearing models and in cancer immunotherapy; preliminary data have indicated great potential for the use of these compounds to detect IDO-positive tumors and as pharmacodynamics indicators with remarkable specificity and sensitivity.